Scientists showed in a new study published Thursday that they could use blood draws to build a “clock” for Alzheimer’s disease that could roughly predict whensymptoms will develop, findings that could eventually transform how the illness is diagnosed and treated.
The Alzheimer’s Drug Discovery Foundation (ADDF) today announced Randall J. Bateman, MD, the Charles F. and Joanne Knight Distinguished Professor of Neurology at Washington University School of Medicine in St. Louis, will receive the 2026 Melvin R. Goodes Prize for Excellence in Drug Development. Dr. Bateman will be honored for his groundbreaking leadership in Alzheimer’s diagnostics and […]
Researchers at Washington University School of Medicine in St. Louis have developed a method to predict when someone is likely to develop symptoms of Alzheimer’s disease using a single blood test. In a new study published Feb. 19 in Nature Medicine, the researchers demonstrated that their models predicted the onset of Alzheimer’s symptoms within a […]
A single blood test may be able to predict when a person will develop Alzheimer’s symptoms—years before memory loss begins—according to new research from the Washington University School of Medicine in St Louis. According to the researchers, their concept could estimate the age of onset of Alzheimer’s symptoms to within three to four years—an ability that could transform both […]
The Department of Neurology at WashU Medicine is proud to announce that it has been ranked No. 2 in NIH funding among all neurology departments across the U.S. This prestigious ranking reflects the exceptional dedication and groundbreaking work of our faculty, staff and trainees. Department leadership would like to extend their heartfelt gratitude to all […]
WashU Medicine Neurology is proud to announce that three of our faculty members have been selected to receive 2026 Dean’s Impact Awards. Nominees are nominated by colleagues for this honor, which recognizes faculty whose work in community engagement strengthens the Medical School’s mission to advance health, innovation and education on local, national and global levels. […]
The Department of Neurology is pleased to announce our Neurology Residency Program chief residents for the 2026-2027 academic year. This group of remarkable individuals will be working with their resident colleagues, staff, faculty and leadership to continue strengthening our program as a leader in neurology residency training. Thank you to our current chief residents, Drs. […]
Claire Clelland, MD, PhD, MPhil, an assistant professor of neurology at the University of California, San Francisco Weill Institute for Neurosciences, has been selected as the winner of the 2025 WashU Medicine Bold Pioneer Award. A ceremony to celebrate her will be held April 24, 2026, in the Jeffrey T. Fort Neuroscience Research Building Auditorium […]
Chimeric antigen receptor (CAR) T cell therapy, a type of immunotherapy that leverages the immune system to combat diseases, is a powerful treatment option for certain cancers. The treatment relies on genetically modified T cells — a type of immune cell — to destroy cancer cells.
Parkinson’s disease, a progressive neurological disorder affecting more than 1 million people in the U.S. and more than 10 million globally, is characterized by debilitating symptoms such as tremors, movement difficulties, sleep disturbances and cognitive impairments. While current treatments, including long-term medication and invasive deep brain stimulation (DBS), can alleviate symptoms, they cannot halt progression […]